. Bioalliance, BioAlliance Pharma obtient le statut de médicament orphelin pour la doxorubicine Transdrug® en Europe pour le traitement du carcinome hépatocellulaire, 1104.

F. Cournarie, D. Auchere, D. Chevenne, B. Lacour, M. Seiller et al., Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats, International Journal of Pharmaceutics, vol.242, issue.1-2, pp.325-333, 2002.
DOI : 10.1016/S0378-5173(02)00175-8

F. Cui, K. Shi, L. Zhang, A. Tao, and Y. Kawashima, Biodegradable nanoparticles loaded with insulin???phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation, Journal of Controlled Release, vol.114, issue.2, pp.242-50, 2006.
DOI : 10.1016/j.jconrel.2006.05.013

C. Damgé, C. Michel, M. Aprahamian, and P. Couvreur, New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier, Diabetes, vol.37, issue.2, pp.246-251, 1988.
DOI : 10.2337/diab.37.2.246

D. Rosa, G. Larobina, D. Immacolata-la-rotonda, M. Musto, P. Quaglia et al., How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-[beta]-cyclodextrin system

A. C. Foss, T. Goto, M. Morishita, and N. A. Peppas, Development of acrylic-based copolymers for oral insulin delivery, European Journal of Pharmaceutics and Biopharmaceutics, vol.57, issue.2, pp.163-172, 2004.
DOI : 10.1016/S0939-6411(03)00145-0

M. A. Radwan and H. Y. Aboul-enein, The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats, Journal of Microencapsulation, vol.19, issue.2, pp.225-235, 2002.
DOI : 10.1080/02652040110081406

C. P. Reis, A. J. Ribeiro, S. Houng, F. Veiga, and R. J. Neufeld, Nanoparticulate delivery system for insulin: Design, characterization and in vitro/in vivo bioactivity, European Journal of Pharmaceutical Sciences, vol.30, issue.5, pp.30-392, 2007.
DOI : 10.1016/j.ejps.2006.12.007

C. H. Zheng, J. Q. Gao, W. Q. Liang, H. Y. Yu, and Y. L. Zhang, Effects of additives and processing parameters on the initial burst release of protein from poly(lactic-co-glycolic acid) microspheres, PDA J Pharm Sci Technol, issue.1, pp.60-54, 2006.

R. Benita, S. Levy, and M. Y. , Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration: Comprehensive Physicochemical Characterization, Journal of Pharmaceutical Sciences, vol.82, issue.11, pp.1069-1079, 1993.
DOI : 10.1002/jps.2600821102

J. Brange and L. Langkjaer, Insulin Formulation and Delivery, Pharm Biotechnol, vol.10, pp.343-409, 1997.
DOI : 10.1007/0-306-46803-4_13

M. G. Carlson and P. J. Campbell, Intensive insulin therapy and weight gain in IDDM, Diabetes, issue.12, pp.42-1700, 1993.

H. Chen and R. Langer, Oral particulate delivery: status and future trends, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.339-350, 1998.
DOI : 10.1016/S0169-409X(98)00047-7

C. Damgé, P. Maincent, and N. Ubrich, Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats, Journal of Controlled Release, vol.117, issue.2, pp.163-170, 2007.
DOI : 10.1016/j.jconrel.2006.10.023

C. Damgé, C. Michel, M. Aprahamian, and P. Couvreur, New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier, Diabetes, vol.37, issue.2, pp.246-251, 1988.
DOI : 10.2337/diab.37.2.246

C. Damgé, C. P. Reis, and P. Maincent, Nanoparticle strategies for the oral delivery of insulin, Expert Opinion on Drug Delivery, vol.13, issue.1, pp.45-68, 2008.
DOI : 10.1111/j.1464-5491.2004.01160.x

C. Damgé, H. Vranckx, P. Balschmidt, and P. Couvreur, Poly(alkyl cyanoacrylate) Nanospheres for Oral Administration of Insulin, Journal of Pharmaceutical Sciences, vol.86, issue.12, pp.1403-1409, 1997.
DOI : 10.1021/js970124i

V. Hoffart, A. Lamprecht, P. Maincent, T. Lecompte, C. Vigneron et al., Oral bioavailability of a low molecular weight heparin using a polymeric delivery system, Journal of Controlled Release, vol.113, issue.1, pp.38-42, 2006.
DOI : 10.1016/j.jconrel.2006.03.020

V. Hoffart, N. Ubrich, A. Lamprecht, K. Bachelier, C. Vigneron et al., Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic Polymers, Drug Delivery, vol.10, issue.1, pp.1-7, 2003.
DOI : 10.1080/713840325

S. R. Jameela, N. Suma, and A. Jayakrishnan, Protein release from poly(??-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study, Journal of Biomaterials Science, Polymer Edition, vol.20, issue.6, pp.457-466, 1997.
DOI : 10.1016/0378-5173(94)90201-1

Y. Jiao, N. Ubrich, M. Marchand-arvier, C. Vigneron, M. Hoffman et al., In Vitro and In Vivo Evaluation of Oral Heparin-Loaded Polymeric Nanoparticles in Rabbits, Circulation, vol.105, issue.2, pp.230-235, 2002.
DOI : 10.1161/hc0202.101988

Y. Y. Jiao, N. Ubrich, V. Hoffart, M. Marchand-arvier, C. Vigneron et al., Preparation and Characterization of Heparin-Loaded Polymeric Microparticles, Drug Development and Industrial Pharmacy, vol.20, issue.13, pp.28-1033, 2002.
DOI : 10.1021/js9603257

F. G. Banting, C. H. Best, J. B. Collip, W. R. Campbell, and A. A. Fletcher, Pancreatic extracts in the treatment of diabetes mellitus, Can. Med. Assoc. J, pp.12-141, 1922.

D. Daneman, Type 1 diabetes, The Lancet, vol.367, issue.9513, pp.847-858, 2006.
DOI : 10.1016/S0140-6736(06)68341-4

D. R. Owens, B. Zinman, and G. Bolli, Alternative routes of insulin delivery, Diabetic Medicine, vol.357, issue.11, pp.886-898, 2003.
DOI : 10.1016/S0140-6736(00)03631-X

C. Damgé, C. Pinto-reis, and P. Maincent, Nanoparticle strategies for the oral delivery of insulin, Expert Opinion on Drug Delivery, vol.13, issue.1, pp.45-68, 2008.
DOI : 10.1111/j.1464-5491.2004.01160.x

H. Liu, R. Tang, W. S. Pan, Y. Zhang, H. Liu-bhavsar et al., Potential utility of various protease References Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using faetorial design, J. Control Rel, vol.110, pp.422-430, 2006.

. R. Bodmeier, . J. @bullet-meginity, and . @bullet, Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method, International Journal of Pharmaceutics, vol.43, issue.1-2, pp.179-186, 1988.
DOI : 10.1016/0378-5173(88)90073-7

C. Bouissou, . J. Rouse, R. Priee, and C. F. Van-der-waue, The Influence of Surfactant on PLGA Microsphere Glass Transition and Water Sorption: Remodeling the Surface Morphology to Attenuate the Burst Release, Pharmaceutical Research, vol.86, issue.7, pp.1295-1305, 2006.
DOI : 10.1248/cpb.40.2870

N. O. Dhoot and M. A. Wheatley, Microencapsulated Liposomes in Controlled Drug Delivery: Strategies to Modulate Drug Release and Eliminate the Burst Effect, Journal of Pharmaceutical Sciences, vol.92, issue.3, pp.679-689, 2003.
DOI : 10.1002/jps.19104

A. Femandez-carbauido, R. Herrero-vanreu, 1. T. Molina-martinez, and P. Pastoriza, Biodegradable ibuprofen-Ioaded PLGA microspheres for intraartieular administration. Effeet of Labrafil addition on release in vitro. lnt, J. Pharm, vol.279, pp.33-41, 2004.

T. Freytag, A. Dashevsky, L. Tiuman, G. E. Hardee, and R. Bodmeier, Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres, Journal of Controlled Release, vol.69, issue.1, pp.197-207, 2000.
DOI : 10.1016/S0168-3659(00)00299-6

K. Fu, R. Harrell, K. Zinski, . Um, A. Jaklenee et al., A Potential Approach for Decreasing the Burst Effect of Protein from PLGA Microspheres, Journal of Pharmaceutical Sciences, vol.92, issue.8, pp.1582-1591, 2003.
DOI : 10.1002/jps.10414

A. Grenha, B. Seijo, and C. Remunan-lopez, Mieroeneapsulated ehitosan nanoparticles for lung protein delivery. Eur, J. Pharm. Sei, vol.25, pp.427-437, 2005.

B. Guiziou, D. 1. Armstrong, !. Elliot, P. N. Ford, and J. L. Rostron, release characteristics of NSAID-loaded polylactic acid microspheres, Journal of Microencapsulation, vol.30, issue.6, pp.701-708, 1996.
DOI : 10.1111/j.2042-7158.1978.tb13365.x

V. Hoffart, N. Ubrieh, . Simonin, . Babak, . Vigneron et al., Low molecular weight heparin-Ioaded polymerie nanopartieles: formulation, eharaeterization, and release eharaeteristies . Drug Dev, lnd. Pharm, vol.28, pp.1091-2000, 2002.

A. S. Hasan, Effect of the microencapsulation of nanoparticles on the reduction of burst release, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.53-61, 2007.
DOI : 10.1016/j.ijpharm.2007.05.066

X. Huang and . Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, Journal of Controlled Release, vol.73, issue.2-3, pp.121-136, 2001.
DOI : 10.1016/S0168-3659(01)00248-6

Y. Y. Huang, T. W. Chung, and T. W. Tzeng, A method using biodegradable polylactides/polyethylene glycol for drug release with reduced initial burst. lnt, J. Pharm, vol.182, pp.93-100, 1999.

J. Huang, R. Wigent, and J. B. Schwartz, Nifedipine Molecular Dispersion in Microparticles of Ammonio Methacrylate Copolymer and Ethylcellulose Binary Blends for Controlled Drug Delivery: Effect of Matrix Composition, Drug Development and Industrial Pharmacy, vol.43, issue.12, pp.1185-1197, 2006.
DOI : 10.1016/S0031-6865(97)00005-8

R. Hurteaux, F. Edwards-levy, D. Laurent-maquin, and M. C. Levy, Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide, European Journal of Pharmaceutical Sciences, vol.24, issue.2-3, pp.187-197, 2005.
DOI : 10.1016/j.ejps.2004.10.010

URL : https://hal.archives-ouvertes.fr/inserm-00069190

G. Jiang, B. E. Thanoo, and P. P. Deluca, Effect of Osmotic Pressure in the Solvent Extraction Phase on BSA Release Profile from PLGA Microspheres, Pharmaceutical Development and Technology, vol.26, issue.4, pp.391-399, 2002.
DOI : 10.1248/cpb.45.1539

W. Leach, D. Simpson, T. N. Val, E. E. Anuta, Z. Yu et al., Uniform Encapsulation of Stable Protein Nanoparticles Produced by Spray Freezing for the Reduction of Burst Release, Journal of Pharmaceutical Sciences, vol.94, issue.1, pp.56-69, 2005.
DOI : 10.1002/jps.20209

T. H. Lee, J. Wang, and E. H. Wang, Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies, Journal of Controlled Release, vol.83, issue.3, pp.437-452, 2002.
DOI : 10.1016/S0168-3659(02)00235-3

K. E. Lee, S. H. Cho, H. B. Lee, S. Y. Jeong, Y. et al., Microencapsulation of lipid nanoparticles containing lipophilic drug, Journal of Microencapsulation, vol.20, issue.4, pp.489-496, 2003.
DOI : 10.1080/0265204031000093032

K. Levis, M. E. Lane, and . Corrigan, Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen. lnt, J. Pharm, vol.253, issue.1, pp.49-59, 2003.

H. Maeda, T. Nakagawa, N. Adachi, Y. Sakai, T. Yamamoto et al., Design of long-acting formulation of protein drugs with a double-layer structure and its application to rhG-CSF, Journal of Controlled Release, vol.91, issue.3, pp.281-297, 2003.
DOI : 10.1016/S0168-3659(03)00247-5

T. K. Mandai, L. A. Bostanian, R. A. Graves, and S. R. Chapman, PolY(D,t.- Lactide-Co-Glycolide) encapsulated poly(Vinyl Alcohol) hydrogel as a drug delivery system, Pharmaceutical Research, vol.19, issue.11, pp.1713-1719, 2002.
DOI : 10.1023/A:1020765615379

S. Nicoli, P. Santi, P. Couvreur, G. Couarraze, P. Colombo et al., Design of triptorelin loaded nanospheres for transdermal iontophoretic administration, International Journal of Pharmaceutics, vol.214, issue.1-2, pp.31-35, 2001.
DOI : 10.1016/S0378-5173(00)00632-3

M. Saravanan, K. Bhaskar, G. Srinivasa-rao, and M. D. Dhanaraju, Ibuprofen-Ioaded ethylcellulose/polystyrene microspheres: an approach to get prolonged drug release with reduced burst elfect and low ethylcellulose content, J. Microencapsul, vol.20, pp.289-302, 2003.

Y. Schuetz, A. Naik, R. Guy, E. Vuaridel, and Y. Kalia, Transdermal Iontophoretic Delivery of Triptorelin in Vitro, Journal of Pharmaceutical Sciences, vol.94, issue.10, pp.2175-2182, 2005.
DOI : 10.1002/jps.20433

S. Hasan, A. Maincent, P. Lamprecht, A. Rissmann, R. Ubrich et al., A drug delivery system based on the encapsulation of nanoparticles in microparticles, AAPS J, vol.6, p.3290, 2004.

R. 1. Stenekes, A. E. Loebis, E. M. Fernandes, D. 1. Crommelin, and W. E. Hennink, Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept, Pharm. Res, vol.17, pp.690-95, 2000.

C. J. Thompson, D. Hansford, S. Higgins, . Rostron, G. A. Hutcheon et al., Evaluation ofibuprofen-Ioaded microspheres prepared from novel copolyesters, pp.53-61, 2007.

A. 1. Thote, J. T. Chappell, R. Gupta, and R. Kumar, Reduction in the Initial-Burst Release by Surface Crosslinking of PLGA Microparticles Containing Hydrophilic or Hydrophobic Drugs, Drug Development and Industrial Pharmacy, vol.82, issue.1, pp.43-57, 2005.
DOI : 10.1002/jps.2600810912

H. T. Wang, E. Schmitt, D. R. Flanagan, and R. Linhardt, Influence of formulation methods on the in vitro controlled release of protein from poly (ester) microspheres, Journal of Controlled Release, vol.17, issue.1, pp.23-31, 1991.
DOI : 10.1016/0168-3659(91)90127-Y

Y. Yamaguchi, M. Takenaga, A. Kitagawa, Y. Ogawa, Y. Mizushima et al., Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives, Journal of Controlled Release, vol.81, issue.3, pp.235-249, 2002.
DOI : 10.1016/S0168-3659(02)00060-3

Y. Yeo and K. Park, Control of encapsulation efficiency and initial burst in polymeric microparticle systems, Archives of Pharmacal Research, vol.17, issue.1, pp.1-12, 2004.
DOI : 10.1248/cpb.45.1539

M. Ardy, Dosage de l'héparine : étude cinétique, Bull. Ordre, vol.137, pp.699-707, 1976.

V. D. Awasthi, D. Garcia, B. A. Goins, and W. T. Phillips, Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits, International Journal of Pharmaceutics, vol.253, issue.1-2, pp.121-132, 2003.
DOI : 10.1016/S0378-5173(02)00703-2

D. Bazile, C. Prud-'homme, M. T. Bassoullet, M. Marlard, G. Spenlehauer et al., Stealth Me. PEG???PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System, Journal of Pharmaceutical Sciences, vol.84, issue.4, pp.493-498, 1995.
DOI : 10.1002/jps.2600840420

A. Béduneau, P. Saulnier, N. Anton, F. Hindré, C. Passirani et al., Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties, Pharmaceutical Research, vol.134, issue.109, pp.2190-2199, 2006.
DOI : 10.1007/s11095-006-9061-y

C. Bocca, O. Caputo, R. Cavalli, L. Gabriel, A. Miglietta et al., Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles, International Journal of Pharmaceutics, vol.175, issue.2, pp.185-193, 1998.
DOI : 10.1016/S0378-5173(98)00282-8

G. J. Charrois and T. M. Allen, Multiple Injections of Pegylated Liposomal Doxorubicin: Pharmacokinetics and Therapeutic Activity, Journal of Pharmacology and Experimental Therapeutics, vol.306, issue.3, pp.1058-1067, 2003.
DOI : 10.1124/jpet.103.053413

Y. V. Chernysheva, V. G. Babak, N. R. Kildeeva, F. Boury, J. P. Benoit et al., Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification???solvent evaporation, Mendeleev Communications, vol.13, issue.2, pp.65-67, 2003.
DOI : 10.1070/MC2003v013n02ABEH001690

C. Damgé, P. Maincent, and N. Ubrich, Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats, Journal of Controlled Release, vol.117, issue.2, pp.163-170, 2007.
DOI : 10.1016/j.jconrel.2006.10.023

C. Damgé, C. Michel, M. Aprahamian, and P. Couvreur, New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier, Diabetes, vol.37, issue.2, pp.246-251, 1988.
DOI : 10.2337/diab.37.2.246

H. P. Ekre, Y. Naparstek, O. Lider, P. Hyden, O. Hagermark et al., Anti-Inflammatory Effects of Heparin and its Derivatives Inhibition of Complement and of Lymphocyte Migration, Adv Exp Med Biol, vol.313, pp.329-340, 1992.
DOI : 10.1007/978-1-4899-2444-5_32

C. Fang, B. Shi, and Y. Y. Pei, Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles1, Acta Pharmacologica Sinica, vol.22, issue.2, pp.242-249, 2005.
DOI : 10.1016/S0378-5173(99)00447-0

C. Fang, B. Shi, Y. Y. Pei, M. H. Hong, J. Wu et al., In vivo tumor targeting of tumor necrosis factor-??-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size, European Journal of Pharmaceutical Sciences, vol.27, issue.1, pp.27-36, 2006.
DOI : 10.1016/j.ejps.2005.08.002

G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona, Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake, Biomaterials, vol.22, issue.21, pp.2857-2865, 2001.
DOI : 10.1016/S0142-9612(01)00030-8

A. Fundaro, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara et al., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats, Pharmacological Research, vol.42, issue.4, pp.337-343, 2000.
DOI : 10.1006/phrs.2000.0695

S. Furtado, D. Abramson, L. Simhkay, D. Wobbekind, and E. Mathiowitz, Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic rats, European Journal of Pharmaceutics and Biopharmaceutics, vol.63, issue.2, pp.229-236, 2006.
DOI : 10.1016/j.ejpb.2005.12.012

Q. Gan and T. Wang, Chitosan nanoparticle as protein delivery carrier???Systematic examination of fabrication conditions for efficient loading and release, Colloids and Surfaces B: Biointerfaces, vol.59, issue.1, pp.24-34, 2007.
DOI : 10.1016/j.colsurfb.2007.04.009

U. Gaur, S. K. Sahoo, T. K. De, P. C. Ghosh, A. Maitra et al., Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system, International Journal of Pharmaceutics, vol.202, issue.1-2, pp.1-10, 2000.
DOI : 10.1016/S0378-5173(99)00447-0

J. K. Gbadamosi, A. C. Hunter, and S. M. Moghimi, PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance, FEBS Letters, vol.10, issue.3, pp.338-344, 2002.
DOI : 10.3109/08982100009031112

R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie et al., ???Stealth??? corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids and Surfaces B: Biointerfaces, vol.18, issue.3-4, pp.301-313, 2000.
DOI : 10.1016/S0927-7765(99)00156-3

G. Gregoriadis, P. D. Leathwood, and B. E. Ryman, Enzyme entrapment in liposomes, FEBS Letters, vol.135, issue.2, pp.95-99, 1971.
DOI : 10.1016/0005-2736(67)90094-6

V. Hoffart, N. Ubrich, A. Lamprecht, K. Bachelier, C. Vigneron et al., Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic Polymers, Drug Delivery, vol.10, issue.1, pp.1-7, 2003.
DOI : 10.1080/713840325

M. J. Hsu and R. L. Juliano, Interactions of liposomes with the reticuloendothelial system, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.720, issue.4, pp.411-419, 1982.
DOI : 10.1016/0167-4889(82)90120-3

M. Huang, W. Wu, J. Qian, D. J. Wan, X. L. Wei et al., Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles1, Acta Pharmacologica Sinica, vol.36, issue.12, pp.1512-1518, 2005.
DOI : 10.1016/0304-4165(93)90105-H

S. R. Jameela, N. Suma, and A. Jayakrishnan, Protein release from poly(??-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study, Journal of Biomaterials Science, Polymer Edition, vol.20, issue.6, pp.457-466, 1997.
DOI : 10.1016/0378-5173(94)90201-1

N. Jaulin, M. Appel, C. Passirani, G. Barratt, and D. Labarre, Reduction of the Uptake by a Macrophagic Cell Line of Nanoparticles Bearing Heparin or Dextran Covalently Bound to Poly(methyl methacrylate), Journal of Drug Targeting, vol.13, issue.3, pp.165-172, 2000.
DOI : 10.1084/jem.147.2.409

Y. Y. Jiao, N. Ubrich, V. Hoffart, M. Marchand-arvier, C. Vigneron et al., Preparation and Characterization of Heparin-Loaded Polymeric Microparticles, Drug Development and Industrial Pharmacy, vol.20, issue.13, pp.1033-1041, 2002.
DOI : 10.1021/js9603257

M. D. Kazatchkine, D. T. Fearon, J. E. Silbert, and K. F. Austen, Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b, Journal of Experimental Medicine, vol.150, issue.5, pp.1202-1215, 1979.
DOI : 10.1084/jem.150.5.1202

E. Kedar, H. Gur, I. Babai, S. Samira, S. Even-chen et al., Delivery of Cytokines by Liposomes: Hematopoietic and Immunomodulatory Activity of Interleukin-2 Encapsulated in Conventional Liposomes and in Long-Circulating Liposomes, Journal of Immunotherapy, vol.23, issue.1, pp.131-145, 2000.
DOI : 10.1097/00002371-200001000-00016

D. Labarre, C. Vauthier, C. Chauvierre, B. Petri, R. Muller et al., Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush, Biomaterials, vol.26, issue.24, pp.5075-5084, 2005.
DOI : 10.1016/j.biomaterials.2005.01.019

D. J. Labarre, Heparin-like Polymer Surfaces: Control of Coagulation and Complement Activation by Insoluble Functionalized Polymers, The International Journal of Artificial Organs, vol.11, issue.10, pp.651-657, 1990.
DOI : 10.1002/eji.1830110405

K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, J. D. Lambris et al., Effect of complement inhibition and heparin coating on artificial surface???induced leukocyte and platelet activation, The Annals of Thoracic Surgery, vol.77, issue.3, pp.932-941, 2004.
DOI : 10.1016/S0003-4975(03)01519-4

C. Lemarchand, R. Gref, C. Passirani, E. Garcion, B. Petri et al., Influence of polysaccharide coating on the interactions of nanoparticles with biological systems, Biomaterials, vol.27, issue.1, pp.108-118, 2006.
DOI : 10.1016/j.biomaterials.2005.04.041

T. S. Levchenko, R. Rammohan, A. N. Lukyanov, K. R. Whiteman, and V. P. Torchilin, Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating, International Journal of Pharmaceutics, vol.240, issue.1-2, pp.95-102, 2002.
DOI : 10.1016/S0378-5173(02)00129-1

Y. Li, Y. Pei, X. Zhang, Z. Gu, Z. Zhou et al., PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats, Journal of Controlled Release, vol.71, issue.2, pp.203-211, 2001.
DOI : 10.1016/S0168-3659(01)00218-8

W. Liu, A. Yang, Z. Li, H. Xu, and X. Yang, PEGylated PLGA nanoparticles as tumor ecrosis factor? receptor blocking peptide carriers: Preparation, characterization and release in vitro, pp.112-116, 2007.

F. Maillet, M. D. Kazatchkine, D. Glotz, E. Fischer, and M. Rowe, Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b, Molecular Immunology, vol.20, issue.12, pp.1401-1404, 1983.
DOI : 10.1016/0161-5890(83)90172-4

P. Maincent, L. Verge, R. Sado, P. Couvreur, P. Devissaguet et al., Disposition Kinetics and Oral Bioavailability of Vincamine-Loaded Polyalkyl Cyanoacrylate Nanoparticles, Journal of Pharmaceutical Sciences, vol.75, issue.10, pp.955-958, 1986.
DOI : 10.1002/jps.2600751009

L. Marchal-heussler, P. Thouvenot, M. Hoffman, and P. Maincent, Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic(-D,L-85/15 and poly(epsilon caprolactone) nanocapsules, Journal of Pharmaceutical Sciences, vol.88, issue.4, pp.450-453, 1999.
DOI : 10.1021/js980307k

M. M. Mayer, . Thomas, S. M. Moghimi, A. C. Hunter, and J. C. Murray, Experimental Immunochemistry Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol Rev, vol.53, pp.283-318, 1961.

S. M. Moghimi, K. D. Pavey, and A. C. Hunter, Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908, FEBS Letters, vol.18, issue.1-3, pp.177-182, 2003.
DOI : 10.1615/CritRevTherDrugCarrierSyst.v18.i6.30

P. Moslemi, A. R. Najafabadi, and H. Tajerzadeh, A rapid and sensitive method for simultaneous determination of insulin and A21-desamido insulin by high-performance liquid chromatography, Journal of Pharmaceutical and Biomedical Analysis, vol.33, issue.1, pp.45-51, 2003.
DOI : 10.1016/S0731-7085(03)00336-4

R. H. Muller, S. Maassen, C. Schwarz, and W. Mehnert, Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes, Journal of Controlled Release, vol.47, issue.3, pp.261-269, 1997.
DOI : 10.1016/S0168-3659(97)01653-2

T. Okuda, S. Kawakami, T. Maeie, T. Niidome, F. Yamashita et al., Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration, Journal of Controlled Release, vol.114, issue.1, pp.69-77, 2006.
DOI : 10.1016/j.jconrel.2006.05.009

R. C. Oppenheim, Solid colloidal drug delivery systems: Nanoparticles, International Journal of Pharmaceutics, vol.8, issue.3, pp.217-234, 1981.
DOI : 10.1016/0378-5173(81)90100-9

C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sciences, vol.62, issue.8, pp.775-785, 1998.
DOI : 10.1016/S0024-3205(97)01175-2

C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate), Pharmaceutical Research, vol.15, issue.7, pp.1046-1050, 1998.
DOI : 10.1023/A:1011930127562

P. Quellec, R. Gref, E. Dellacherie, F. Sommer, M. D. Tran et al., Protein encapsulation within poly(ethylene glycol)-coated nanospheres. II. Controlled release properties, Journal of Biomedical Materials Research, vol.50, issue.3, pp.388-395, 1999.
DOI : 10.1007/978-94-011-0571-2_4

P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer et al., Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization, Journal of Biomedical Materials Research, vol.15, issue.1, pp.45-54, 1998.
DOI : 10.1023/A:1011922819926

L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra, and R. R. Murthy, Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies, The AAPS Journal, vol.6, issue.3, p.23, 2004.
DOI : 10.1208/aapsj060323

M. Roser, D. Fischer, and T. Kissel, Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats, European Journal of Pharmaceutics and Biopharmaceutics, vol.46, issue.3, 1998.
DOI : 10.1016/S0939-6411(98)00038-1

S. Sengupta, P. Tyagi, T. Velpandian, Y. K. Gupta, and S. K. Gupta, Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies, Pharmacological Research, vol.42, issue.5, pp.459-464, 2000.
DOI : 10.1006/phrs.2000.0714

M. Socha, A. Lamprecht, F. Ghazouani, E. Emond, P. Maincent et al., Increase in the Vascular Residence Time of Propranolol-Loaded Nanoparticles Coated with Heparin, Journal of Nanoscience and Nanotechnology, vol.8, issue.5, pp.2369-2376, 2008.
DOI : 10.1166/jnn.2008.081

M. Tobio, R. Gref, A. Sanchez, R. Langer, and M. J. Alonso, Stealth PLA-PEG nanoparticles as protein carriers for nasal administration, Pharmaceutical Research, vol.15, issue.2, pp.270-275, 1998.
DOI : 10.1023/A:1011922819926

T. Verrecchia, G. Spenlehauer, D. V. Bazile, A. Murry-brelier, Y. Archimbaud et al., Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers, Journal of Controlled Release, vol.36, issue.1-2, pp.49-61, 1995.
DOI : 10.1016/0168-3659(95)00053-B

M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard et al., Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators, Biomaterials, vol.17, issue.16, pp.1575-1581, 1996.
DOI : 10.1016/0142-9612(95)00322-3

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. C. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006.
DOI : 10.1007/978-1-4613-2433-1_26

X. Xu, Y. Fu, H. Hu, Y. Duan, and Z. Zhang, Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography, Journal of Pharmaceutical and Biomedical Analysis, vol.41, issue.1, pp.266-273, 2006.
DOI : 10.1016/j.jpba.2005.10.016

A. Yang, L. Yang, W. Liu, Z. Li, H. Xu et al., Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vitro evaluation, International Journal of Pharmaceutics, vol.331, issue.1, pp.123-132, 2007.
DOI : 10.1016/j.ijpharm.2006.09.015

M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron, Preparation and characterization of protein C-loaded PLA nanoparticles, Journal of Controlled Release, vol.60, issue.2-3, pp.179-188, 1999.
DOI : 10.1016/S0168-3659(99)00073-5

/. Xa, En effet, il n'est pas envisageable qu'un tel modèle de particules furtives possède un effet anticoagulant lors d'un traitement thérapeutique

. Enfin, des molécules, comme l'interféron alfa qui existe aujourd'hui sous forme

M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damge, Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Biology of the Cell, vol.61, issue.1-2, pp.61-61, 1987.
DOI : 10.1111/j.1768-322X.1987.tb00571.x

D. Bazile, C. Prud-'homme, M. T. Bassoullet, M. Marlard, G. Spenlehauer et al., Stealth Me. PEG???PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System, Journal of Pharmaceutical Sciences, vol.84, issue.4, pp.84-493, 1995.
DOI : 10.1002/jps.2600840420

A. Beletsi, Z. Panagi, and K. Avgoustakis, Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA???PEG diblock copolymers, International Journal of Pharmaceutics, vol.298, issue.1, pp.233-274, 2005.
DOI : 10.1016/j.ijpharm.2005.03.024

C. Bocca, O. Caputo, R. Cavalli, L. Gabriel, A. Miglietta et al., Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles, International Journal of Pharmaceutics, vol.175, issue.2, pp.175-175, 1998.
DOI : 10.1016/S0378-5173(98)00282-8

J. Brange, D. R. Owens, S. Kang, and A. Volund, Monomeric Insulins and Their Experimental and Clinical Implications, Diabetes Care, vol.13, issue.9, pp.923-54, 1990.
DOI : 10.2337/diacare.13.9.923

C. Damgé, M. Aprahamian, W. Humbert, and M. Pinget, Ileal Uptake of Polyalkylcyanoacrylate Nanocapsules in the Rat, Journal of Pharmacy and Pharmacology, vol.137, issue.9, pp.52-52, 2000.
DOI : 10.1148/radiology.137.1.6252571

C. Damgé, P. Maincent, and N. Ubrich, Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats, Journal of Controlled Release, vol.117, issue.2, pp.117-117, 2007.
DOI : 10.1016/j.jconrel.2006.10.023

C. Damgé, C. Michel, M. Aprahamian, P. Couvreur, and J. P. Devissaguet, Nanocapsules as carriers for oral peptide delivery, Journal of Controlled Release, vol.13, issue.2-3, pp.13-13, 1990.
DOI : 10.1016/0168-3659(90)90013-J

C. Damgé, C. P. Reis, and P. Maincent, Nanoparticle strategies for the oral delivery of insulin, Expert Opinion on Drug Delivery, vol.13, issue.1, pp.45-68, 2008.
DOI : 10.1111/j.1464-5491.2004.01160.x

D. Rosa, G. Larobina, D. Immacolata-la-rotonda, M. Musto, P. Quaglia et al., How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-[beta]-cyclodextrin system

A. Des-rieux, V. Fievez, M. Garinot, Y. J. Schneider, and V. Preat, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach, Journal of Controlled Release, vol.116, issue.1, pp.116-116, 2006.
DOI : 10.1016/j.jconrel.2006.08.013

N. O. Dhoot and M. A. Wheatley, Microencapsulated Liposomes in Controlled Drug Delivery: Strategies to Modulate Drug Release and Eliminate the Burst Effect, Journal of Pharmaceutical Sciences, vol.92, issue.3, pp.92-92, 2003.
DOI : 10.1002/jps.19104

C. Fang, B. Shi, P. , and Y. Y. , Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles, Acta Pharmacol Sin, issue.2, pp.242-251, 2005.

C. Fang, B. Shi, Y. Y. Pei, M. H. Hong, J. Wu et al., In vivo tumor targeting of tumor necrosis factor-??-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size, European Journal of Pharmaceutical Sciences, vol.27, issue.1, pp.27-27, 2006.
DOI : 10.1016/j.ejps.2005.08.002

G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona, Amoxicillinloaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake, Biomaterials, vol.22, issue.2221, pp.22-22, 2001.

A. Fundaro, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara et al., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats, Pharmacological Research, vol.42, issue.4, pp.42-42, 2000.
DOI : 10.1006/phrs.2000.0695

U. Gaur, S. K. Sahoo, T. K. De, P. C. Ghosh, A. Maitra et al., Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system, International Journal of Pharmaceutics, vol.202, issue.1-2, pp.1-10, 2000.
DOI : 10.1016/S0378-5173(99)00447-0

J. K. Gbadamosi, A. C. Hunter, and S. M. Moghimi, PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance, FEBS Letters, vol.10, issue.3, pp.532-532, 2002.
DOI : 10.3109/08982100009031112

R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie et al., ???Stealth??? corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption, Colloids and Surfaces B: Biointerfaces, vol.18, issue.3-4, pp.18-18, 2000.
DOI : 10.1016/S0927-7765(99)00156-3

V. Hoffart, A. Lamprecht, P. Maincent, T. Lecompte, C. Vigneron et al., Oral bioavailability of a low molecular weight heparin using a polymeric delivery system, Journal of Controlled Release, vol.113, issue.1, pp.113-113, 2006.
DOI : 10.1016/j.jconrel.2006.03.020

M. Huang, W. Wu, J. Qian, D. J. Wan, X. L. Wei et al., Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles1, Acta Pharmacologica Sinica, vol.36, issue.12, pp.26-26, 2005.
DOI : 10.1016/0304-4165(93)90105-H

N. Jaulin, M. Appel, C. Passirani, G. Barratt, and D. Labarre, Reduction of the Uptake by a Macrophagic Cell Line of Nanoparticles Bearing Heparin or Dextran Covalently Bound to Poly(methyl methacrylate), Journal of Drug Targeting, vol.13, issue.3, pp.8-8, 2000.
DOI : 10.1084/jem.147.2.409

Y. Jiao, N. Ubrich, M. Marchand-arvier, C. Vigneron, M. Hoffman et al., In Vitro and In Vivo Evaluation of Oral Heparin-Loaded Polymeric Nanoparticles in Rabbits, Circulation, vol.105, issue.2, pp.105-105, 2002.
DOI : 10.1161/hc0202.101988

H. K. Kim, J. H. Hong, M. S. Park, J. S. Kang, and M. H. Lee, Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection, Biomedical Chromatography, vol.4, issue.8
DOI : 10.1248/bpb1978.4.879

P. Kurtzhals, L. Schaffer, A. Sorensen, C. Kristensen, I. Jonassen et al., Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use, Diabetes, vol.49, issue.6, pp.49-49, 2000.
DOI : 10.2337/diabetes.49.6.999

G. Lambert, J. R. Bertrand, E. Fattal, F. Subra, H. Pinto-alphandary et al., EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice, Biochemical and Biophysical Research Communications, vol.279, issue.2, pp.279-279, 2000.
DOI : 10.1006/bbrc.2000.3963

U. M. Le and Z. Cui, Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy, International Journal of Pharmaceutics, vol.312, issue.1-2, pp.312-312, 2006.
DOI : 10.1016/j.ijpharm.2006.01.002

J. K. Li, N. Wang, and X. S. Wu, A Novel Biodegradable System Based on Gelatin Nanoparticles and Poly(lactic-co-glycolic acid) Microspheres for Protein and Peptide Drug Delivery, Journal of Pharmaceutical Sciences, vol.86, issue.8, pp.86-86, 1997.
DOI : 10.1021/js970084i

Y. Li, Y. Pei, X. Zhang, Z. Gu, Z. Zhou et al., PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats, Journal of Controlled Release, vol.71, issue.2, pp.71-71, 2001.
DOI : 10.1016/S0168-3659(01)00218-8

J. Liu, S. M. Zhang, P. P. Chen, L. Cheng, W. Zhou et al., Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels, Journal of Materials Science: Materials in Medicine, vol.83, issue.11, pp.18-18, 2007.
DOI : 10.1023/A:1013674200141

W. Liu, A. Yang, Z. Li, H. Xu, Y. et al., PEGylated PLGA nanoparticles as tumor ecrosis factor-?? receptor blocking peptide carriers: Preparation, characterization and release in vitro, Journal of Wuhan University of Technology-Mater. Sci. Ed., vol.4, issue.6, pp.22-22, 1922.
DOI : 10.1016/S0142-9612(03)00331-4

A. Maksimenko, C. Malvy, G. Lambert, J. R. Bertrand, E. Fattal et al., Oligonucleotides targeted against a junction oncogene are made efficient by nanotechnologies, Pharm Res, vol.20, issue.10, pp.20-20, 1920.

T. K. Mandal, L. A. Bostanian, R. A. Graves, and S. R. Chapman, Poly(D,L-lactide-coglycolide ) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system, Pharm Res, issue.11, pp.19-1713, 2002.

M. K. Marschutz and A. Bernkop-schnurch, Oral peptide drug delivery: polymer???inhibitor conjugates protecting insulin from enzymatic degradation in vitro, Biomaterials, vol.21, issue.14, pp.21-21, 2000.
DOI : 10.1016/S0142-9612(00)00039-9

E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chickering et al., Biologically erodable microspheres as potential oral drug delivery systems, Nature, vol.386, issue.6623, pp.386-386, 1997.
DOI : 10.1038/386410a0

M. Mesiha, F. Plakogiannis, and S. Vejosoth, Enhanced oral absorption of insulin from desolvated fatty acid-sodium glycocholate emulsions, International Journal of Pharmaceutics, vol.111, issue.3, pp.111-111, 1994.
DOI : 10.1016/0378-5173(94)90343-3

M. S. Mesiha, S. Ponnapula, and F. Plakogiannis, Oral absorption of insulin encapsulated in artificial chyles of bile salts, palmitic acid and alpha-tocopherol dispersions, Int J Pharm, vol.249, issue.24912, pp.249-250, 2002.

S. M. Moghimi, K. D. Pavey, and A. C. Hunter, Real-time evidence of surface modification at polystyrene lattices by poloxamine 908 in the presence of serum: in vivo conversion of macrophage-prone nanoparticles to stealth entities by poloxamine 908, FEBS Letters, vol.18, issue.1-3, pp.547-547, 2003.
DOI : 10.1615/CritRevTherDrugCarrierSyst.v18.i6.30

R. H. Müller, S. Maassen, C. Schwarz, and W. Mehnert, Solid lipid nanaoparticles (SLN) as potential carrier for human use: interaction with human granulocytes, Journal of Controlled Release, pp.47-47, 1997.

R. H. Muller, S. Maassen, C. Schwarz, and W. Mehnert, Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes, Journal of Controlled Release, vol.47, issue.3, pp.47-47, 1997.
DOI : 10.1016/S0168-3659(97)01653-2

Y. Nakada, R. Tudomi, K. Sakurai, and Y. Takahashi, Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(l-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo, International Journal of Pharmaceutics, vol.175, issue.1, pp.175-175, 1998.
DOI : 10.1016/S0378-5173(98)00280-4

T. Okuda, S. Kawakami, T. Maeie, T. Niidome, F. Yamashita et al., Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration, Journal of Controlled Release, vol.114, issue.1, pp.114-114, 2006.
DOI : 10.1016/j.jconrel.2006.05.009

C. G. Oster, N. Kim, L. Grode, L. Barbu-tudoran, A. K. Schaper et al., Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination, Journal of Controlled Release, vol.104, issue.2, pp.104-104, 2005.
DOI : 10.1016/j.jconrel.2005.02.004

C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sciences, vol.62, issue.8, pp.62-62, 1998.
DOI : 10.1016/S0024-3205(97)01175-2

C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate)

M. T. Peracchia, E. Fattal, D. Desmaele, M. Besnard, J. P. Noel et al., Stealth?? PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting, Journal of Controlled Release, vol.60, issue.1, pp.60-60, 1999.
DOI : 10.1016/S0168-3659(99)00063-2

M. T. Peracchia, S. Harnisch, H. Pinto-alphandary, A. Gulik, J. C. Dedieu et al., Visualization of in vitro protein-rejecting properties of PEGylated stealth?? polycyanoacrylate nanoparticles, Biomaterials, vol.20, issue.14, pp.20-20, 1920.
DOI : 10.1016/S0142-9612(99)00021-6

M. T. Peracchia, C. Vauthier, F. Puisieux, and P. Couvreur, Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol), Journal of Biomedical Materials Research, vol.210, issue.3, pp.34-34, 1997.
DOI : 10.1016/0040-6031(93)80461-I

H. Pinto-alphandary, M. Aboubakar, D. Jaillard, P. Couvreur, and C. Vauthier, Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats, Pharm Res, vol.20, issue.7, pp.20-20, 1920.

P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer et al., Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization, Journal of Biomedical Materials Research, vol.15, issue.1, pp.42-42, 1998.
DOI : 10.1023/A:1011922819926

G. S. Rekhi, S. S. Jambhekar, P. F. Souney, W. , and D. A. , A fluorimetric liquid chromatographic method for the determination of propranolol in human serum/plasma, Journal of Pharmaceutical and Biomedical Analysis, vol.13, issue.12
DOI : 10.1016/0731-7085(95)01575-2

Y. Sadzuka, A. Nakade, R. Hirama, A. Miyagishima, Y. Nozawa et al., Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome, International Journal of Pharmaceutics, vol.238, issue.1-2, pp.238-171, 2002.
DOI : 10.1016/S0378-5173(02)00075-3

S. M. Setter, C. F. Corbett, R. K. Campbell, and J. R. White, Insulin aspart: a new rapidacting insulin analog, Ann Pharmacother, vol.34, issue.3412, pp.34-34, 2000.

B. Shi, C. Fang, M. X. You, Y. Zhang, S. Fu et al., Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice, Colloid and Polymer Science, vol.34, issue.9, pp.283-283, 2005.
DOI : 10.1007/s00396-004-1243-8

N. Toub, J. R. Bertrand, A. Tamaddon, H. Elhamess, H. Hillaireau et al., Efficacy of siRNA Nanocapsules Targeted Against the EWS???Fli1 Oncogene in Ewing Sarcoma, Pharmaceutical Research, vol.1235, issue.8, pp.23-23, 2006.
DOI : 10.1128/MCB.13.12.7393

N. Ubrich, P. Bouillot, C. Pellerin, M. Hoffman, and P. Maincent, Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study, Journal of Controlled Release, vol.97, issue.2, pp.97-97, 2004.
DOI : 10.1016/j.jconrel.2004.03.023

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. C. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.78-78, 2006.
DOI : 10.1007/978-1-4613-2433-1_26

J. Wang, B. M. Wang, and S. P. Schwendeman, Mechanistic evaluation of the glucoseinduced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-coglycolide ) microspheres, Biomaterials, issue.10, pp.1919-1946, 2004.

A. Yamamoto, T. Taniguchi, K. Rikyuu, T. Tsuji, T. Fujita et al., Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats, Pharm Res, vol.11, issue.1110, pp.11-11, 1994.

A. Yang, L. Yang, W. Liu, Z. Li, H. Xu et al., Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vitro evaluation, International Journal of Pharmaceutics, vol.331, issue.1, pp.331-331, 2007.
DOI : 10.1016/j.ijpharm.2006.09.015

M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron, Preparation and characterization of protein C-loaded PLA nanoparticles, Journal of Controlled Release, vol.60, issue.2-3, pp.60-60, 1999.
DOI : 10.1016/S0168-3659(99)00073-5

M. F. Zambaux, B. Faivre-fiorina, F. Bonneau, S. Marchal, J. L. Merlin et al., Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig, Biomaterials, vol.21, issue.10, pp.21-21, 2000.
DOI : 10.1016/S0142-9612(99)00233-1

C. H. Zheng, J. Q. Gao, W. Q. Liang, H. Y. Yu, and Y. L. Zhang, Effects of additives and processing parameters on the initial burst release of protein from poly(lactic-co-glycolic acid) microspheres, PDA J Pharm Sci Technol, vol.60, issue.1, pp.60-60, 2006.